Silo Pharma, INC DEF 14A proxy statements

Silo Pharma, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for August 14, 2026, to elect directors, ratify auditors, and approve a significant increase in authorized common stock.

Silo Pharma, Inc. announced its 2025 Annual Meeting agenda, including director elections, auditor ratification, a proposed reverse stock split, and an equity incentive plan amendment.

Silo Pharma, Inc. announces its 2025 Annual Meeting of Shareholders to vote on director elections, auditor ratification, a reverse stock split, and an equity plan amendment.

Silo Pharma has announced its 2024 Annual Meeting of Stockholders to be held on December 20, 2024, where shareholders will vote on the election of directors, ratification of the accounting firm, executive compensation, and other key proposals.

Silo Pharma has rescheduled its 2024 annual meeting of stockholders from November 12, 2024, to December 20, 2024, and established a new record date.

Silo Pharma will hold its annual meeting of stockholders on November 12, 2024, to vote on director elections, auditor ratification, executive compensation, and other proposals.

Silo Pharma announces its 2024 Annual Meeting of Stockholders to be held on November 12, 2024, featuring proposals for director elections, auditor ratification, executive compensation, and meeting adjournment authorization.